Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Clariscan

Drug Contrast Media

NDC 0407-2943-01

Open in the dashboard

General payments

$57,010

24 payments

Research payments

$0

0 payments

Through program year 2020, $57,010 in general payments and $0 in research payments were reported against Clariscan (Contrast Media).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2020 General $57,010 24

Breakdown

Who paid General payments · program year 2020
  1. Ge Healthcare $57,010 24 payments
Top recipients General payments · program year 2020
  1. Lawrence Tanenbaum Diagnostic Radiology · New York, NY $40,105 70% · 8 payments
  2. Donna Roberts Diagnostic Radiology · Charleston, SC $9,024 16% · 6 payments
  3. Max Wintermark Diagnostic Radiology · Houston, TX $2,500 4% · 1 payment
  4. Scott Reeder Diagnostic Radiology · Madison, WI $2,500 4% · 1 payment
  5. Franklin Moser Neuroradiology · Los Angeles, CA $2,333 4% · 4 payments

The top 5 of 7 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Diagnostic Radiology Radiology $54,677 96% · 6 practitioners
  2. Neuroradiology Radiology $2,333 4% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. New York $40,105 70% · 1 recipient
  2. North Carolina $9,024 16% · 1 recipient
  3. California $4,833 8% · 2 recipients
  4. Wisconsin $2,500 4% · 1 recipient
  5. Minnesota $346 <1% · 1 recipient

The top 5 of 6 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Given in the clinic

Part B · billing code
Billing code Providers Services Paid by Medicare
Injection, gadoterate meglumine, 0.1 ml A9575 3,298 53,453,861 $5,063,147

Drugs given by a clinician are billed to Medicare Part B, not Part D. The product is tied to a billing code through the NDC on CMS's crosswalk, which was published for a later quarter than the payments, so a code that changed in between can be missed. Providers with fewer than 11 patients for the code are not published. Medicare's payment here is what it paid for the services, to the billing practice.

Records

24 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record